Jessen, F, Frölich, L, Hort, J, Winblad, B, Fortea, J. Amyloid-lowering treatment in Alzheimer's disease. LANCET. 2024; 404(10468)DOI:10.1016/S0140-6736(24)02510-8. PMID:39551061. IF:88.500(Q1/1D).

Dubois, B, Villain, N, Schneider, L, Fox, N, Campbell, N, Galasko, D, Kivipelto, M, Jessen, F, Hanseeuw, B, Boada, M, Barkhof, F, Nordberg, A, Froelich, L, Waldemar, G, Frederiksen, KS, Padovani, A, Planche, V, Rowe, C, Bejanin, A, Ibanez, A, Cappa, S, Caramelli, P, Nitrini, R, Allegri, R, Slachevsky, A, de Souza, LC, Bozoki, A, Widera, E, Blennow, K, Ritchie, C, Agronin, M, Lopera, F, Delano-Wood, L, Bombois, S, Levy, R, Thambisetty, M, Georges, J, Jones, DT, Lavretsky, H, Schott, J, Gatchel, J, Swantek, S, Newhouse, P, Feldman, HH, Frisoni, GB. Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation. JAMA Neurology. 2024; 81(12)DOI:10.1001/jamaneurol.2024.3770. PMID:39483064. IF:21.300(Q1/1D).

Therriault, J, Janelidze, S, Benedet, AL, Ashton, NJ, Martínez, JA, Gonzalez-Escalante, A, Bellaver, B, Alcolea, D, Vrillon, A, Karim, H, Mielke, MM, Hong, CH, Roh, HW, Contador, J, Pijoan, AP, Algeciras-Schimnich, A, Vemuri, P, Graff-Radford, J, Lowe, VJ, Karikari, TK, Jonaitis, E, Brum, W, Tissot, C, Servaes, S, Rahmouni, N, Macedo, AC, Stevenson, J, Fernandez-Arias, J, Wang, YT, Woo, MS, Friese, MA, Jia, WL, Dumurgier, J, Hourregue, C, Cognat, E, Ferreira, PL, Vitali, P, Johnson, S, Pascoal, TA, Gauthier, S, Lleó, A, Paquet, C, Petersen, RC, Salmon, D, Mattsson-Carlgren, N, Palmqvist, S, Stomrud, E, Galasko, D, Son, SJ, Zetterberg, H, Fortea, J, Suárez-Calvet, M, Jack, CR, Blennow, K, Hansson, O, Rosa-Neto, P. Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability. Nature Aging. 2024; 4(11)DOI:10.1038/s43587-024-00731-y. PMID:39533113. IF:19.400(Q1/1D).

Caillaud, M, Laisney, M, Bejanin, A, Duclos, H, Scherer-Gagou, C, Prundean, A, Bonneau, D, Eustache, F, Verny, C, Desgranges, B, Allain, P. Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging. Journal Of Huntingtons Disease. 2024; 13(4)DOI:10.1177/18796397241291730. PMID:39973378. IF:(Q/D).

Cano, A, Capdevila, M, Puerta, R, Arranz, J, Montrreal, L, de Rojas, I, García-González, P, Olivé, C, García-Gutiérrez, F, Sotolongo-Grau, O, Orellana, A, Aguilera, N, Ramis, M, Rosende-Roca, M, Lleó, A, Fortea, J, Tartari, JP, Lafuente, A, Vargas, L, Pérez-Cordón, A, Muñoz, N, Sanabria, A, Alegret, M, Morató, X, Tárraga, L, Fernández, V, Marquié, M, Valero, S, Alcolea, D, Boada, M, Ruiz, A. Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105345. PMID:39299003. IF:10.800(Q1/1D).

Pascoal, TA, Aguzzoli, CS, Lussier, FZ, Crivelli, L, Suemoto, CK, Fortea, J, Rosa-Neto, P, Zimmer, ER, Ferreira, PCL, Bellaver, B. Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105322. PMID:39366844. IF:10.800(Q1/1D).

Carmona-Iragui, M, 'Connor, AO, Llibre-Guerra, J, Lao, PT, Ashton, NJ, Fortea, J, Sánchez-Valle, R. Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105327. PMID:39366843. IF:10.800(Q1/1D).

Schöll, M, Verberk, IMW, del Campo, M, Delaby, C, Therriault, J, Chong, JR, Palmqvist, S, Alcolea, D. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Lancet Healthy Longevity. 2024; 5(10)DOI:10.1016/j.lanhl.2024.07.013. PMID:39369727. IF:14.600(Q1/1D).